These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31172720)

  • 21. A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD.
    Feldman G; Maltais F; Khindri S; Vahdati-Bolouri M; Church A; Fahy WA; Trivedi R
    Int J Chron Obstruct Pulmon Dis; 2016; 11():719-30. PubMed ID: 27103795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of tiotropium in children aged 1-5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trial.
    Vrijlandt EJLE; El Azzi G; Vandewalker M; Rupp N; Harper T; Graham L; Szefler SJ; Moroni-Zentgraf P; Sharma A; Vulcu SD; Sigmund R; Chawes B; Engel M; Bisgaard H
    Lancet Respir Med; 2018 Feb; 6(2):127-137. PubMed ID: 29361462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tiotropium as an add-on treatment to inhaled corticosteroids in children with severe and mild symptomatic asthma: Multi-center observational study for efficacy and safety analysis.
    Aierken A; Yu Su Fu BWMEM; Xu P
    Exp Ther Med; 2022 Sep; 24(3):577. PubMed ID: 35949336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tiotropium added to low- to medium-dose inhaled corticosteroids (ICS) versus low- to medium-dose ICS alone for adults with mild to moderate uncontrolled persistent asthma: A systematic review and meta-analysis.
    Wang L; Zhou R; Xie X
    J Asthma; 2019 Jan; 56(1):69-78. PubMed ID: 29420077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics of GSK961081, a bi-functional molecule, in patients with COPD.
    Bateman ED; Kornmann O; Ambery C; Norris V
    Pulm Pharmacol Ther; 2013 Oct; 26(5):581-7. PubMed ID: 23538170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA.
    Bernstein D; Andersen L; Forth R; Jacques L; Yates L
    J Asthma; 2018 Sep; 55(9):984-993. PubMed ID: 28961020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of the dual bronchodilator combination umeclidinium/vilanterol in COPD by age and airflow limitation severity: A pooled post hoc analysis of seven clinical trials.
    Ray R; Tombs L; Naya I; Compton C; Lipson DA; Boucot I
    Pulm Pharmacol Ther; 2019 Aug; 57():101802. PubMed ID: 31096036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD.
    Sethi S; Kerwin E; Watz H; Ferguson GT; Mroz RM; Segarra R; Molins E; Jarreta D; Garcia Gil E
    Int J Chron Obstruct Pulmon Dis; 2019; 14():667-682. PubMed ID: 30962681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is the role of tiotropium in asthma?: a systematic review with meta-analysis.
    Rodrigo GJ; Castro-Rodríguez JA
    Chest; 2015 Feb; 147(2):388-396. PubMed ID: 25322075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vilanterol and fluticasone furoate for asthma.
    Dwan K; Milan SJ; Bax L; Walters N; Powell C
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD010758. PubMed ID: 27582089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined treatment with formoterol and tiotropium is more efficacious than treatment with tiotropium alone in patients with chronic obstructive pulmonary disease, regardless of smoking status, inhaled corticosteroid use, baseline severity, or gender.
    Tashkin DP; Varghese ST
    Pulm Pharmacol Ther; 2011 Feb; 24(1):147-52. PubMed ID: 20659577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials.
    Decramer M; Anzueto A; Kerwin E; Kaelin T; Richard N; Crater G; Tabberer M; Harris S; Church A
    Lancet Respir Med; 2014 Jun; 2(6):472-86. PubMed ID: 24835833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses.
    Tashkin D; Kesten S
    Chest; 2003 May; 123(5):1441-9. PubMed ID: 12740259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk.
    Covelli H; Pek B; Schenkenberger I; Scott-Wilson C; Emmett A; Crim C
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1-12. PubMed ID: 26730183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD.
    Manoharan A; Morrison AE; Lipworth BJ
    Lung; 2016 Apr; 194(2):259-66. PubMed ID: 26758884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study.
    Singh D; Pujol H; Ribera A; Seoane B; Massana E; Astbury C; Ruiz S; de Miquel G
    BMC Pulm Med; 2014 Nov; 14():176. PubMed ID: 25398689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.
    Bateman ED; van Dyk M; Sagriotis A
    Pulm Pharmacol Ther; 2008; 21(1):20-5. PubMed ID: 17118684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The efficacy and safety of tiotropium/olodaterol fixed-dose combination in Chinese patients with chronic obstructive pulmonary disease: a pooled subgroup analysis of TONADO 1+2].
    Bai CX; Tang Y; Xin JB; Li YL; Li ZK; Kang J; Huang JA; Xiao W; Wen ZG; Fu XH; He B; Liu CT; Chen P
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Nov; 42(11):838-844. PubMed ID: 31694094
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy and Safety of Tiotropium in the Treatment of Severe Persistent Asthma:Meta-analysis.
    Lou LL; Gong HH; Zhang MQ; Gao JM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Feb; 38(1):62-8. PubMed ID: 26956858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.